(Q80267688)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17479993%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Aminocyclitols as pharmacological chaperones for glucocerebrosidase, a defective enzyme in Gaucher disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17479993%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17479993%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Amadeu Llebaria

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17479993%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Meritxell Egido-Gabás

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17479993%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Josefina Casas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17479993%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Antonio Delgado

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17479993%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17479993%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17479993%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17479993%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17479993%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

992-994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17479993%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic strategies to ameliorate lysosomal storage disorders--a focus on Gaucher disease

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Chemical chaperones--a new concept in drug research

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Pharmacological chaperones: a new twist on receptor folding.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Pharmacotherapeutic strategies using small molecules for the treatment of glycolipid lysosomal storage disorders

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Gaucher disease: Perspectives on a prototype lysosomal disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Gaucher's disease: a paradigm for interventional genetics.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

New directions in the treatment of Gaucher disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Enzyme replacement and enhancement therapies: lessons from lysosomal disorders

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Enzyme replacement and enhancement therapies for lysosomal diseases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Rational design and synthesis of highly potent beta-glucocerebrosidase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Alpha-1-C-octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Design and synthesis of highly potent and selective pharmacological chaperones for the treatment of Gaucher's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

N-octyl-beta-valienamine up-regulates activity of F213I mutant beta-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

New aminocyclitols as modulators of glucosylceramide metabolism

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Combinatorial approach to N-substituted aminocyclitol libraries by solution-phase parallel synthesis and preliminary evaluation as glucocerebrosidase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Regio- and stereoselective synthesis of aminoinositols and 1,2-diaminoinositols from conduritol B epoxide

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Alpha-1-C-alkyl-1-deoxynojirimycin derivatives as potent and selective inhibitors of intestinal isomaltase: remarkable effect of the alkyl chain length on glycosidase inhibitory profile

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

The role of cysteine residues in structure and enzyme activity of a maize beta-glucosidase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700061

7 January 2021

Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of ...

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1021/CI00063A006

12 September 2021

Identifiers

DOI

10.1002/CMDC.200700061

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17479993%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference